Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: inclusion body myopathy with Paget disease and frontotemporal dementia | Statement: [TDP-43 proteinopathy, associatedWithDisease, inclusion body myopathy with Paget disease and frontotemporal dementia]

Target entity: inclusion body myopathy with Paget disease and frontotemporal dementia
Context triple: [TDP-43 proteinopathy, associatedWithDisease, inclusion body myopathy with Paget disease and frontotemporal dementia]

• A. TDP-43 proteinopathy
  TDP-43 proteinopathy is a neurodegenerative condition characterized by abnormal aggregation and mislocalization of the TDP-43 protein, commonly implicated in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• B. SOD1
  SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
• C. Cln3
  Cln3 is a G1 cyclin in budding yeast that helps trigger the Start transition of the cell cycle by activating the Cdc28 cyclin-dependent kinase.
• D. C9orf72
  C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• E. progressive supranuclear palsy
  Progressive supranuclear palsy is a rare neurodegenerative movement disorder characterized by early postural instability, vertical gaze palsy, and cognitive and behavioral changes due to widespread tau pathology in the brain.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: inclusion body myopathy with Paget disease and frontotemporal dementia
Target entity description: Inclusion body myopathy with Paget disease and frontotemporal dementia is a rare, inherited multisystem degenerative disorder characterized by progressive muscle weakness, bone abnormalities, and early-onset cognitive and behavioral decline.

• A. TDP-43 proteinopathy
  TDP-43 proteinopathy is a neurodegenerative condition characterized by abnormal aggregation and mislocalization of the TDP-43 protein, commonly implicated in disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• B. SOD1
  SOD1 is a gene encoding the antioxidant enzyme superoxide dismutase 1, whose mutations are a major known cause of familial amyotrophic lateral sclerosis (ALS).
• C. Cln3
  Cln3 is a G1 cyclin in budding yeast that helps trigger the Start transition of the cell cycle by activating the Cdc28 cyclin-dependent kinase.
• D. C9orf72
  C9orf72 is a human gene whose hexanucleotide repeat expansions are the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• E. Pompe disease
  Pompe disease is a rare inherited metabolic disorder caused by deficiency of the enzyme acid alpha-glucosidase, leading to progressive muscle weakness and cardiomyopathy due to glycogen buildup in cells.
• F. None of above. chosen